<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion Models - Health AI Hub</title>
    <meta name="description" content="Apo2Mol introduces a novel diffusion-based generative framework for 3D small molecule design that overcomes the rigid protein assumption prevalent in current ap">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Apo2Mol: 3D Molecule Generation via Dynamic Pocket-Aware Diffusion Models</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.14559v1" target="_blank">2511.14559v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-18
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Xinzhe Zheng, Shiyu Jiang, Gustavo Seabra, Chenglong Li, Yanjun Li
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> q-bio.BM, cs.AI, cs.LG, q-bio.QM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.14559v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.14559v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">Apo2Mol introduces a novel diffusion-based generative framework for 3D small molecule design that overcomes the rigid protein assumption prevalent in current approaches. It simultaneously generates high-affinity ligand molecules and their corresponding flexible protein binding pocket conformations from an apo state, leveraging a curated dataset of experimentally resolved apo-holo structure pairs. This method achieves state-of-the-art performance in ligand generation and accurately models realistic protein conformational changes.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for advancing structure-based drug discovery by enabling the design of more effective and specific small molecule ligands that account for the dynamic nature of protein targets, leading to improved drug candidates with potentially fewer off-target effects.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>Apo2Mol is a generative AI model (diffusion-based) applied to health by facilitating de novo drug design. It uses AI to predict and generate novel small molecules (ligands) that can potentially serve as drug candidates, simultaneously modeling their binding to flexible protein targets. This accelerates the early stages of drug discovery by proposing molecules with desired properties, thereby contributing to the development of new treatments for diseases.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical limitation of rigid protein binding pocket assumptions in existing deep generative models for drug design.</li>
                    
                    <li>Proposes Apo2Mol, a diffusion-based generative framework designed for 3D molecule design that explicitly accounts for protein conformational flexibility.</li>
                    
                    <li>Utilizes a full-atom hierarchical graph-based diffusion model to simultaneously generate 3D ligand molecules and their corresponding holo pocket conformations from input apo protein states.</li>
                    
                    <li>Leverages a curated dataset of over 24,000 experimentally resolved apo-holo structure pairs from the Protein Data Bank to characterize ligand-induced protein structure changes.</li>
                    
                    <li>Achieves state-of-the-art performance in generating high-affinity ligand molecules.</li>
                    
                    <li>Demonstrates accurate capture of realistic protein pocket conformational changes upon ligand binding.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>Apo2Mol is a diffusion-based generative framework employing a full-atom hierarchical graph-based diffusion model. It is trained on a curated dataset of over 24,000 experimentally resolved apo-holo protein structure pairs. The model is designed to simultaneously generate 3D ligand molecules and the corresponding flexible holo pocket conformations from an initial apo protein state, thereby explicitly modeling ligand-induced conformational changes.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Empirical studies demonstrate that Apo2Mol achieves state-of-the-art performance in generating high-affinity ligand molecules. Furthermore, the model accurately captures realistic protein pocket conformational changes that occur upon ligand binding, a critical aspect often neglected by rigid protein assumptions.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>By providing a more accurate and realistic approach to ligand design that accounts for protein flexibility, Apo2Mol can accelerate the identification and optimization of novel drug candidates. This could lead to more potent, selective, and clinically successful drugs, reducing the high failure rates in preclinical and clinical drug development and potentially bringing new treatments to patients faster.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>Not explicitly mentioned in the abstract.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Not explicitly mentioned in the abstract.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Structural Biology</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Bioinformatics</span>
                    
                    <span class="tag">Computational Biology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Drug design</span>
                    
                    <span class="tag tag-keyword">Diffusion models</span>
                    
                    <span class="tag tag-keyword">Protein flexibility</span>
                    
                    <span class="tag tag-keyword">Ligand generation</span>
                    
                    <span class="tag tag-keyword">Binding pockets</span>
                    
                    <span class="tag tag-keyword">Conformational changes</span>
                    
                    <span class="tag tag-keyword">Apo-holo structures</span>
                    
                    <span class="tag tag-keyword">Structure-based drug design</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Deep generative models are rapidly advancing structure-based drug design, offering substantial promise for generating small molecule ligands that bind to specific protein targets. However, most current approaches assume a rigid protein binding pocket, neglecting the intrinsic flexibility of proteins and the conformational rearrangements induced by ligand binding, limiting their applicability in practical drug discovery. Here, we propose Apo2Mol, a diffusion-based generative framework for 3D molecule design that explicitly accounts for conformational flexibility in protein binding pockets. To support this, we curate a dataset of over 24,000 experimentally resolved apo-holo structure pairs from the Protein Data Bank, enabling the characterization of protein structure changes associated with ligand binding. Apo2Mol employs a full-atom hierarchical graph-based diffusion model that simultaneously generates 3D ligand molecules and their corresponding holo pocket conformations from input apo states. Empirical studies demonstrate that Apo2Mol can achieve state-of-the-art performance in generating high-affinity ligands and accurately capture realistic protein pocket conformational changes.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Accepted by AAAI 2026</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>